Boothbay Fund Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,500
Closed -$814K 1941
2024
Q1
$814K Sell
2,500
-20,887
-89% -$5.13M 0.02% 817
2023
Q4
$4.46M Buy
23,387
+22,199
+1,869% +$4.2M 0.11% 231
2023
Q3
$237K Buy
+1,188
New +$281K 0.01% 1363
2023
Q1
Sell
-1,872
Closed -$385K 2598
2022
Q4
$385K Buy
1,872
+900
+93% +$228K 0.01% 1279
2022
Q3
$270K Buy
+972
New +$247K 0.01% 1608

Other funds holding SWAV

Boothbay Fund Management's SWAV Position: Q2 2024 in Review

Boothbay Fund Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 2,500 shares — an estimated $814K sold.

Boothbay Fund Management first reported a position in SWAV in Q3 2022 and held it in 5 quarters. The position peaked at $4.46M in Q4 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Boothbay Fund Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 2,500 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $814K.
  • Boothbay Fund Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Boothbay Fund Management's Shockwave Medical, Inc. Common Stock position peaked at $4.46M in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Boothbay Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.